Silje Skrede

1.9k total citations
53 papers, 1.4k citations indexed

About

Silje Skrede is a scholar working on Molecular Biology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Silje Skrede has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Physiology and 13 papers in Psychiatry and Mental health. Recurrent topics in Silje Skrede's work include Diet and metabolism studies (10 papers), Schizophrenia research and treatment (10 papers) and Peroxisome Proliferator-Activated Receptors (8 papers). Silje Skrede is often cited by papers focused on Diet and metabolism studies (10 papers), Schizophrenia research and treatment (10 papers) and Peroxisome Proliferator-Activated Receptors (8 papers). Silje Skrede collaborates with scholars based in Norway, Spain and Netherlands. Silje Skrede's co-authors include Vidar M. Steen, Johan Fernø, Audun Osland Vik‐Mo, Rolf K. Berge, Miguel López, Bjarte Håvik, Carlos Diéguez, María J. Vázquez, Antonio Vidal‐Puig and Kari M. Ersland and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neuropsychopharmacology.

In The Last Decade

Silje Skrede

49 papers receiving 1.4k citations

Peers

Silje Skrede
Andres Stucky United States
Július Benický United States
Heather A. Ferris United States
Lance A. Johnson United States
Mohammad M. Khan United States
Silje Skrede
Citations per year, relative to Silje Skrede Silje Skrede (= 1×) peers Jasminka Štefulj

Countries citing papers authored by Silje Skrede

Since Specialization
Citations

This map shows the geographic impact of Silje Skrede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silje Skrede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silje Skrede more than expected).

Fields of papers citing papers by Silje Skrede

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silje Skrede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silje Skrede. The network helps show where Silje Skrede may publish in the future.

Co-authorship network of co-authors of Silje Skrede

This figure shows the co-authorship network connecting the top 25 collaborators of Silje Skrede. A scholar is included among the top collaborators of Silje Skrede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silje Skrede. Silje Skrede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnsen, Erik, Ole Bernt Fasmer, Solveig Klæbo Reitan, et al.. (2025). Prednisolone add-on in early phase schizophrenia: A randomized, double-blind, placebo-controlled pilot study. Brain Behavior & Immunity - Health. 48. 101047–101047.
2.
Mukherjee, Sayani, Silje Skrede, & Johan Fernø. (2025). The hypothalamus as a therapeutic target: Towards novel approaches for managing antipsychotic-induced weight gain. Reviews in Endocrine and Metabolic Disorders.
3.
Bluett, James, Floris C. Loeff, Mehmet İtik, et al.. (2025). Quality Assessment of Therapeutic Drug Monitoring Assays of Therapeutic Antibodies Across Europe: An Update. Basic & Clinical Pharmacology & Toxicology. 137(5). e70129–e70129.
4.
Skrede, Silje, et al.. (2024). Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model. CNS Neuroscience & Therapeutics. 30(2). e14565–e14565. 3 indexed citations
5.
Kučera, Jan, et al.. (2024). Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model. Biomedicine & Pharmacotherapy. 176. 116763–116763. 1 indexed citations
6.
Skrede, Silje, Nataša Bogavac‐Stanojević, Erwin Dreesen, et al.. (2024). Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across Europe. Basic & Clinical Pharmacology & Toxicology. 134(4). 556–560. 4 indexed citations
7.
Ljostveit, Sonja, Silje Skrede, Nina Langeland, et al.. (2024). Hospitalisations and humoral COVID-19 vaccine response in vaccinated rituximab-treated multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 89. 105770–105770. 1 indexed citations
8.
Johnsen, Erik, et al.. (2023). Dog-assisted interventions for adults diagnosed with schizophrenia and related disorders: a systematic review. Frontiers in Psychiatry. 14. 1192075–1192075. 3 indexed citations
9.
Mukherjee, Sayani, et al.. (2023). Peripheral and central macrophages in obesity. Frontiers in Endocrinology. 14. 1232171–1232171. 13 indexed citations
10.
Skrede, Silje, Ismael González‐García, Luís Martins, et al.. (2017). Lack of Ovarian Secretions Reverts the Anabolic Action of Olanzapine in Female Rats. The International Journal of Neuropsychopharmacology. 20(12). 1005–1012. 15 indexed citations
11.
Grønli, Janne, Peter Meerlo, Ståle Pallesen, et al.. (2016). A Rodent Model of Night-Shift Work Induces Short-Term and Enduring Sleep and Electroencephalographic Disturbances. Journal of Biological Rhythms. 32(1). 48–63. 15 indexed citations
12.
Steine, Iris M., Tetyana Zayats, C. T. Stansberg, et al.. (2016). Implication of NOTCH1 gene in susceptibility to anxiety and depression among sexual abuse victims. Translational Psychiatry. 6(12). e977–e977. 14 indexed citations
13.
Steen, Vidar M., Silje Skrede, Miguel López, et al.. (2016). Genetic evidence for a role of the SREBP transcription system and lipid biosynthesis in schizophrenia and antipsychotic treatment. European Neuropsychopharmacology. 27(6). 589–598. 35 indexed citations
14.
Kroken, Rune A., Else‐Marie Løberg, Renate Grüner, et al.. (2014). A Critical Review of Pro-Cognitive Drug Targets in Psychosis: Convergence on Myelination and Inflammation. Frontiers in Psychiatry. 5. 11–11. 36 indexed citations
15.
Steen, Vidar M., Chirag Nepal, Kari M. Ersland, et al.. (2013). Neuropsychological Deficits in Mice Depleted of the Schizophrenia Susceptibility Gene CSMD1. PLoS ONE. 8(11). e79501–e79501. 60 indexed citations
16.
Skrede, Silje, María J. Vázquez, Audun Osland Vik‐Mo, et al.. (2011). Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat. Psychopharmacology. 219(3). 783–794. 66 indexed citations
17.
Fernø, Johan, Luis Varela, Silje Skrede, et al.. (2011). Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation. PLoS ONE. 6(6). e20571–e20571. 102 indexed citations
18.
Skrede, Silje, Johan Fernø, María J. Vázquez, et al.. (2011). Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats. The International Journal of Neuropsychopharmacology. 15(2). 163–179. 74 indexed citations
19.
Fernø, Johan, Maria B. Ræder, Audun Osland Vik‐Mo, et al.. (2005). Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?. The Pharmacogenomics Journal. 5(5). 298–304. 132 indexed citations
20.
Skrede, Silje, et al.. (1977). Nucleotide pyrophosphatase and phosphodiesterase. I. Organ distribution and activities in body fluids.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(9). 1531–7. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026